Thromb Haemost 2011; 105(02): 279-284
DOI: 10.1160/TH10-09-0570
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

Characterisation of two novel large F8 deletions in patients with severe haemophilia A and factor VIII inhibitors

Lukas Roth
1   University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany
,
Rolf Marschalek
2   Institute of Pharmaceutical Biology / ZAFES / DCAL, Johann-Wolfgang-Goethe-University Frankfurt, Biocenter, Frankfurt/Main, Germany
,
Johannes Oldenburg
3   Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany
,
Florian Oyen
1   University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany
,
Reinhard Schneppenheim
1   University Medical Center Hamburg-Eppendorf, Department of Pediatric Hematology and Oncology, Hamburg, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 07. September 2010

Accepted after minor revision: 25. Oktober 2010

Publikationsdatum:
15. Dezember 2017 (online)

Summary

Large deletions are found in approximately 5% of patients with severe haemophilia A, but only a few deletion breakpoints have been char-acterised precisely so far. In this study we characterised the deletion breakpoints of two patients with severe haemophilia A, large deletions and factor VIII (FVIII) inhibitors, and subsequently established deletion-specific assays for the identification of carriers. Patient 1 had a deletion of 37,410 bp comprising exon 1 and the F8promoter region, and a 5 bp homology (GGGCC) is present at the chromosomal fusion site. In patient 2, a deletion of 22,230 bp including parts of intron 25, exon 26 and 3‘-UTR was identified. No homologous repetitive elements were found at the breakpoints. However, both breakpoints were located within long terminal repeats of endogenous retroviruses and the DNA motif TTTAAA – known to be able to bend DNA molecules – was identified at the centromeric breakpoint. By deletion-specific PCR experiments we were able to identify a heterozygous state in mother 2 (carrier) while mother 1 presented only with wild-type alleles (non-carrier). Both deletions are most likely created by DNA double strand breaks and subsequent DNA repair by the non-homologous end joining DNA repair pathway (NHEJ). The exact identification of the deletion breakpoints provides a reliable diagnostic tool for carrier identification in affected families by means of a deletion-specific PCR.